Geisinger to Perform Routine DNA Sequencing for 1,000 Patients in Pilot Study

We are entering an era in which DNA sequencing will become a routine laboratory test for a high percentage of patients. Geisinger, always a leader in innovation, is beginning the validation of this diagnostic approach (see:Geisinger to perform DNA sequencing as routine care). The key question, of course, is what actions hospital personnel will take based on this DNA information. This question is partly answered in the excerpt from the article below:Geisinger will soon roll out DNA sequencing as part of its preventive care for patients....Over the next six months, the Danville, Pa.-based system will enroll 1,000 patients in a pilot program recommending DNA sequencing as part of routine clinical care. Eventually, Geisinger said will provide clinical DNA sequencing across its Pennsylvania and New Jersey footprint....."This forecasting will allow us to provide truly anticipatory healthcare instead of the responsive sick care that has long been the industry default across the nation [according to the Geisinger CEO]." The health system said in a release DNA sequencing would become a"routine screening" like mammograms, colonoscopies and cholesterol checks for its patients. Physicians will work with their patients to respond to any genomic risk factors found.The pilot will build off of Geisinger's research-focused genomic initiative, known as MyCode Community Health Initiative, that started in 2013 [Should Hospitals Recruit Patients for Drug Company Research P...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Clinical Lab Industry News Clinical Lab Testing Genomic Testing Healthcare Delivery Healthcare Information Technology Healthcare Innovations Lab Industry Trends Lab Processes and Procedures Medical Consumerism Medical Research Medicole Source Type: blogs